Global Substance Use Disorder Treatment Market Poised for Robust Growth, Projected to Reach USD 67.6 Billion by 2034

The global substance use disorder treatment market is poised for significant growth, with sales projected to reach USD 40.3 billion in 2024. Over the forecast period from 2024 to 2034, the market is expected to expand at a compound annual growth rate (CAGR) of 5.3%, culminating in a market size of USD 67.6 billion by the end of 2034.

Several key factors are driving the demand for substance use disorder treatments. The rising prevalence of substance abuse disorders and increasing awareness of available treatments are critical contributors. Government initiatives, such as drug awareness campaigns and prevention programs, are also playing a crucial role. Additionally, the increasing prevalence of opioid use disorders and the growing adoption of Nicotine Replacement Therapy (NRT) are boosting market growth. Technological advancements in therapies and a surge in the launch of awareness programs further support the market’s expansion.

Government efforts to combat drug use problems and the introduction of favorable regulations are pivotal in driving the industry. These initiatives aim to enhance access to treatment and support services for individuals with substance use disorders. As awareness of substance use disorders increases and efforts to destigmatize addiction gain momentum, more individuals are seeking treatment, thereby expanding the patient base for treatment providers.

The growing use of telemedicine and virtual care presents additional opportunities to extend access to substance use disorder treatment, particularly in rural areas where access to traditional treatment centers may be limited. This technological advancement is expected to play a significant role in the future growth of the market.

Key Takeaways: Substance Use Disorder Treatment Market

  • The global market for substance use disorder treatment is expected to reach USD 67.6 billion by 2034, growing at a CAGR of 5.3%.
  • India is projected to have the fastest growth (CAGR of 5.1%) due to increased awareness and reduced stigma surrounding addiction. Public awareness campaigns are encouraging people to seek help.
  • The UK market is expected to grow at a CAGR of 1.6%, driven by the adoption of telemedicine and virtual care solutions. Telemedicine offers increased accessibility and improved patient outcomes.
  • The US market is expected to grow at a CAGR of 1.4%. Collaboration between pharmaceutical companies, healthcare providers, and research institutions is leading to improved treatment options and access. Public-private partnerships are also playing a significant role.

Get Old Source Has the Newest Reports Available

Competitive Landscape:

The substance use disorder (SUD) treatment market is highly competitive and rapidly evolving, driven by increasing demand for effective treatment options. Pharmaceutical companies, rehabilitation centers, and specialized clinics offer a variety of therapies, including medication-assisted treatment (MAT), behavioral therapies, and holistic approaches.

Leading companies in the SUD treatment market are strengthening their positions through mergers and acquisitions. Venture capital and private equity funds are also targeting innovative SUD treatment options, making significant investments in telehealth and digital health companies to mitigate market risks.

Rehabilitation centers promote comprehensive therapy, incorporating medical detox, counseling, and aftercare programs. The introduction of telehealth services has created new competitors, such as BetterHelp, which provides remote counseling and support. Innovation and regulatory changes have a substantial impact, with ongoing research into novel drugs and therapeutic procedures enhancing treatment efficacy.

Recent Developments:

  • March 2023: Indivior plc announced the acquisition of Opiant Pharmaceuticals, Inc., strengthening Indivior’s addiction treatment portfolio with OPNT003, an investigational opioid overdose treatment aimed at addressing the current wave of opioid overdoses in the United States.
  • January 2023: BioCorRx Inc., a developer of innovative treatment programs for substance use and related disorders, provided an update on the Phase I clinical trial of BICX104, an implantable biodegradable naltrexone pellet for the treatment of opioid use disorder (OUD) being developed by BioCorRx Pharmaceuticals, Inc.

Key market players of the substance use disorder treatment market:

  • Teva Pharmaceutical Industries Ltd.
  • Reckitt Benckiser Pharmaceuticals Inc.
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Cipla Limited
  • Intas Biopharmaceuticals
  • Alkermes
  • Allergan plc
  • Alkermes plc.
  • Indivior plc
  • Noramco
  • Mallinckrodt plc
  • BioCorRx Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Dr. Reddy’s Laboratories
  • Purdue Pharma L.P.
  • Orexo AB

Key Segments of the Report:

By Type:

The segment is classified into alcohol abuse treatment, nicotine abuse treatment and drug abuse treatment.

By Treatment:

Based on treatment type, the industry is classified into detoxification, counseling & behavioral therapy, medication and support group.

By Region:

Analysis of the substance use disorder treatment market has been carried out in key countries of North America, Latin America, Western Europe, South Asia, East Asia, Eastern Europe and Middle East & Africa.

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:

The global nonvascular interventional radiology device market size is likely to adhere to a CAGR of 4.9%. The ecosystem is likely to get elevated from USD 27.6 billion in 2024 to the valuation mark of USD 44.6 billion by 2034.

The global next-generation titrator market share is expected to reach USD 7,171.9 million by 2034, owing to a moderate CAGR of 6.5% through the forecast period. The competitive space was measured at USD 3,820.6 million in 2024.

The global pressure infusion cuffs market demand is estimated to ascend at a valuation of approximately USD 350.8 million by 2024 as per Future Market Insights report. The change in industry valuation for the pressure infusion cuffs is likely to be at a moderate CAGR of 5.7% through 2034. The change in value in the ecosystem is estimated to reach a value of USD 610.7 million by the end of the forecast period.

The global venous stents market outlook valued at approximately USD 990.5 million in 2023, is expected to soar to an impressive USD 2.2 billion by the end of 2033. This growth represents a substantial compound annual growth rate (CAGR) of 8.4% from 2023 to 2033.

The global intravenous pegloticase market trends with a slowly progressing CAGR of 13.8% from 2023 to 2033, this market is expected to garner USD 3.19 Billion by 2023 and USD 11.61 Billion by 2033.

The projected global photoacoustic microscopy market opportunity is likely to hit the USD 120 billion valuation mark by 2024. Owing to an impressive CAGR of 17.3% through 2034, the ecosystem is set to reach USD 591.6 million by the end of the forecast period.

The global intravenous iron drugs market forecast is projected to reach USD 2.8 Billion in 2022 and is expected to growth USD 6.3 Billion by 2032 at a CAGR of 8.5%.

The global venous stents market strategies valued at approximately USD 990.5 million in 2023, is expected to soar to an impressive USD 2.2 billion by the end of 2033. This growth represents a substantial compound annual growth rate (CAGR) of 8.4% from 2023 to 2033.

The global intravenous pegloticase market trends with a slowly progressing CAGR of 13.8% from 2023 to 2033, this market is expected to garner USD 3.19 Billion by 2023 and USD 11.61 Billion by 2033.

The global photoacoustic microscopy market overview is likely to hit the USD 120 billion valuation mark by 2024. Owing to an impressive CAGR of 17.3% through 2034, the ecosystem is set to reach USD 591.6 million by the end of the forecast period.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Knotless Tissue Control Devices Market Set to Soar to USD 672.6 Million by 2032

The global knotless tissue control devices market is on a promising growth trajectory, with recent market research projecting a Compound Annual Growth Rate (CAGR) of 3.4% from 2022 to 2032. Valued at USD 465.6 million in 2022, the market is expected to soar to an impressive USD 672.6 million by 2032.

This substantial growth is primarily fueled by the rising demand for minimally invasive procedures and continuous technological advancements in the healthcare sector. Both healthcare providers and patients are increasingly gravitating toward minimally invasive techniques due to their significant benefits, including shorter recovery times and a reduced risk of complications. As a result, the demand for knotless tissue control devices has surged, marking a pivotal shift in modern medical practices.

Minimally invasive procedures have become the cornerstone of contemporary healthcare, offering patients the advantages of less pain, quicker recovery, and fewer post-surgical complications. Knotless tissue control devices play a vital role in these procedures by providing precise and reliable tissue manipulation without the need for traditional sutures. This technology not only enhances surgical outcomes but also significantly boosts patient satisfaction, driving its adoption in healthcare facilities across the globe.

Moreover, continuous technological advancements in knotless tissue control devices are propelling market growth. Innovations in device design and functionality are empowering surgeons to perform complex procedures with increased ease and accuracy. These advancements are not only improving surgical outcomes but also broadening the scope of procedures that can be performed using minimally invasive techniques.

As the global healthcare landscape evolves, the knotless tissue control devices market is poised for sustained growth. The increasing preference for minimally invasive procedures, coupled with ongoing technological innovations, is set to drive the market to unprecedented heights over the next decade.

The global knotless tissue control devices market is being driven by several key factors:

  • Benefits of Knotless Tissue Control Devices: Knotless tissue control devices offer various benefits such as distributing tension along the wound, simplifying knot tying, and reducing knot-related complications. These advantages are expected to increase the demand for these devices in healthcare settings.
  • Rising Number of Surgical Procedures: An increasing number of surgical procedures, including knee replacements, bypass surgeries, hip replacements, and cosmetic surgeries, are anticipated to drive the demand for knotless tissue control devices. As the population ages and the prevalence of conditions requiring surgical intervention rises, the demand for these devices is expected to grow correspondingly.
  • Demographic Trends: The aging population is particularly relevant to the demand for knotless tissue control devices. A study published by the National Centre for Biotechnology Information indicates that approximately 30% of elderly individuals fall due to difficulties in walking, which often necessitates knee replacement surgeries. As the population continues to age globally, the need for such surgical procedures is expected to increase, further driving the demand for knotless tissue control devices.
  • Technological Advancements and Product Innovation: The launch of efficient devices by key players in the market is expected to strengthen the industry. For example, Smith & Nephew launched HELICOIL knotless sutures in September 2020, which utilize bone marrow and associated stem cells to enhance the healing process. Such innovations enhance the effectiveness and usability of knotless tissue control devices, contributing to market growth.

Overall, the convergence of these factors is expected to fuel the growth of the global knotless tissue control devices market in the foreseeable future.

Gain Full Insight: Access the Complete Knotless Tissue Control Devices Market Report

Top of Form

Key Companies Profiled:

  • Johnson & Johnson Services, Inc.
  • Medtronic
  • Ethicon US, LLC. (Subsidiary of Johnson & Johnson)
  • Medline Industries, Inc.

Key Segments Profiled in the Global Knotless Tissue Control Devices Market:

By Product Type:

  • Short-Term
  • Long-Term
  • Nonabsorbable Polymers

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Trauma Centers
  • Medical Device Manufacturers
  • Pharmaceutical Companies
  • Research Centers and Laboratory

By Region:

  • North American
  • Latin American
  • Western European
  • Eastern European
  • Asia-Pacific
  • Japanese
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Digital Health Market Poised for Significant Growth USD 16,603.7 Million by 2034 Driven by Telehealth and Wearable Innovations

The global digital health market is poised for remarkable expansion, with forecasts projecting a surge from USD 8,131.3 million in 2024 to an astounding USD 16,603.7 million by 2034. This significant growth highlights the accelerating adoption of digital health solutions, underpinned by continuous innovations in telehealth and telemedicine, which are anticipated to grow at an annual rate of 7.4%.

Telemedicine, a cornerstone of modern healthcare, has emerged as a transformative force, offering essential services such as remote monitoring and virtual consultations. These advancements have fueled the demand for digital healthcare solutions, enabling healthcare providers to deliver continuous, real-time monitoring of patients’ vital signs. This capability is particularly crucial in managing chronic illnesses and tracking patient recovery status, ensuring more effective and timely interventions.

The integration of wearable technology is another pivotal factor driving the market’s growth. Wearables enable constant monitoring of patients, supporting wellness programs and preventative care businesses. Coupled with the power of data analytics, these devices allow the creation of personalized treatment programs, an advanced form of digital health that is expected to further propel market expansion in the coming years.

As the digital health market continues to evolve, these innovations are expected to play a critical role in enhancing patient outcomes, improving access to care, and ultimately transforming the healthcare landscape.

Key Takeaways from the Digital Health Market Study Report:

  • The overall market is predicted to witness an absolute growth opportunity of USD 8,500 million over the next ten years.
  • The United States is currently the leading market for the adoption of digital health technologies and is likely to advance at 6.8% per year from 2024 to 2034.
  • Demand for digital health services in Germany is predicted to grow at a rate of 6.6% per year through the projected years.
  • India is poised to witness the most lucrative CAGR of 22.5% in the adoption of digital healthcare facilities during the projected years.
  • Thailand is also emerging as a lucrative market for digital health services and is forecasted to be at a rate of 16.4% per year between 2024 and 2034.

Competitive Landscape for the Digital Health Market Participants:

The overall market is witnessing a steep increase in completion these days due to the adoption of digital health services by the continuous entry of established industries in the healthcare sector. However, dedicated digital health service providers hold on to their market position by providing customized medical treatments and maximizing treatment outcomes by taking into account personal patient information.

“A steep rise in smartphone usage has increased the popularity of mobile health applications in both developed and developing countries. Digital healthcare solutions are also helping such patients with features for lifestyle management, medication adherence tools, and remote monitoring.” – says a lead analyst at FMI

Get Old Source Offers the Latest Report Editions

Recent Developments by the Digital Health Industry Players:

In June 2023, the pharmaceutical giant Bayer introduced a precision health unit to increase its investment in consumer-facing digital health products. According to a press statement, the company aims to give top priority to creating digital solutions that help consumers make better decisions about their own health by utilizing unique delivery methods and personal data.

In August 2023, Lupin Digital Health announced the opening of the first-ever digital heart failure clinic launched by Lupin Digital Health. Lupin Digital is a division of Lupin Pharmaceuticals that focuses on cardiac digital therapies and inaugurated its Lyfe Digital Heart Failure Clinic in India. The goal of these e-clinics is to assist cardiologists and caregivers in efficiently managing patients with heart failure from the convenience of their own homes.

Key Players Profiled in the Digital Health Market Report:

  • AT&T Inc.
  • Apple Inc.
  • AirStrip Technologies LP
  • Alcatel-Lucent Corporation
  • Cerner Corporation
  • Symantec Corporation
  • Aruba Networks, Inc.
  • Cisco Systems, Inc.
  • Qualcomm, Inc.
  • Siemens Healthcare
  • Philips Healthcare

Key Segments Covered by Digital Health Industry Survey Report:

By Solution Type:

  • Software
    • Healthcare Payers Software
      • Healthcare Claims Management Software
      • Healthcare CRM Software
      • Payer Care Management Software
      • Other Healthcare Paying Software
  • Healthcare Providers Software
    • EHR or EMR Software
    • E-Prescribing Software
    • Healthcare Asset Management Software
    • Population Health Management Software
    • Other Healthcare Providing Software
  • Services
    • Managed Services
    • Professional Services
      • Healthcare Consulting Services
      • Integration & Implementation Services
      • Support & Maintenance Services
      • Other Professional Services

By Deployment:

  • Cloud-based
  • On-Premises

By End User Verticals:

  • Diagnostics Centers
  • Healthcare Payers
  • Healthcare Research Centers
  • Hospitals & Clinics
  • Nursing Care Centers
  • Other End User Verticals

By Region:

  • North America Market
  • Latin America Market
  • Europe Market
  • East Asia Market
  • South Asia and Pacific Market
  • Middle East and Africa (MEA) Market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Clinical Diagnostics Market on Track for Unprecedented Growth, Expected to Reach USD 126.6 Billion by 2032

The global clinical diagnostics market is on the brink of extraordinary growth, according to a newly released comprehensive market analysis report. The market is projected to achieve a staggering valuation of USD 126.6 billion by 2032, propelled by a robust Compound Annual Growth Rate (CAGR) of 5.5% from 2022 to 2032.

By the end of 2022, the market is expected to total approximately USD 74 billion, marking a substantial increase that highlights the rising demand for advanced diagnostic procedures worldwide. This growth reflects an escalating reliance on accurate and efficient diagnostic tools across a broad spectrum of medical domains.

The surge in market value underscores the critical role of blood tests and other diagnostic procedures in modern healthcare. With the global healthcare landscape increasingly emphasizing early detection and personalized medicine, the need for precise diagnostics has never been more crucial. This demand is driving innovation and expansion within the clinical diagnostics sector, paving the way for advancements that could transform patient outcomes.

Industry experts attribute this growth to several factors, including the rising prevalence of chronic diseases, technological advancements in diagnostic tools, and a growing focus on preventive healthcare. As healthcare providers continue to prioritize accurate and timely diagnoses, the clinical diagnostics market is poised to play an integral role in shaping the future of global healthcare.

Key Highlights of the Report:

  • Global clinical diagnostics market expected to reach USD 126.6 Billion by 2032.
  • Robust Compound Annual Growth Rate (CAGR) of 5.5% projected from 2022 to 2032.
  • Surge fueled by escalating demand for blood tests and other diagnostic procedures.
  • Factors driving growth include technological advancements, expanding healthcare infrastructure, and emphasis on preventive healthcare measures.

As the demand for clinical diagnostics products continues to escalate, stakeholders across the healthcare industry are poised to capitalize on this unprecedented growth opportunity. This surge not only signifies a significant market expansion but also underscores the critical role of diagnostic tools in enhancing patient care and advancing medical outcomes.

Key Takeaways from Clinical Diagnostics Market:

  • North America holds the largest market share with the US being subject to tremendous increase in clinical diagnostics products’ sales coupled with rising incidences of chronic and infectious diseases.
  • The Asia-Pacific is expected to grow at the fastest pace in the clinical diagnostics market. This could be credited to increase in healthcare infrastructure all across India and China.
  • Europe is expected to grow on the similar grounds in the clinical diagnostics market in the forecast period.

Explore the Full Market Scope: Find the Complete Clinical Diagnostics Market Report Here

Competitively Clinical Diagnostics

  • Hoffmann-La Roche Ltd., in March 2021, inked a definitive merger agreement with GenMark Diagnostics Inc. with the objective of helping it to test for a wide spectrum of pathogens through sampling.
  • Ortho Clinical Diagnostics, in September 2021, did announce availability of ISXM (Immediate Spin Crossmatch) under the category of ‘Ortho Vision Max Analyzers’ for helping in detection of incompatibility between donors and recipients in the blood transfusions.
  • TGA (Therapeutic Goods Administration), in January 2022, did grant provisional approval for Nuvaxovid (Covid-19 vaccine by Novavax) for usage in Australia.
  • Mindray, in March 2022, came up with BC-700 Series (a hematology analyzer series helping in erythrosyte sedimentation and blood count rate tests).
  • Qiagen Inc., in May 2022, came up with NeuMoDxHSSV ½ Quant Assay to quantify and differentiate herpes simplex virus type 1 (HSV – 1) DNA and herpes simplex virus type 2 (HSV-2) with the European Commission having approved it.

What does the Report say?

  • The research study is based on test (lipid panel clinical diagnostics, liver panel clinical diagnostics, renal panel clinical diagnostics, complete blood count clinical diagnostics, clinical diagnostics for electrolyte testing, clinical diagnostics for infectious disease testing, and other clinical diagnostics tests), by product (clinical diagnostics instruments, clinical diagnostics reagents, and other clinical diagnostics products), and by end-user (clinical diagnostics for hospital laboratories, clinical diagnostics for diagnostics laboratories, clinical diagnostics for point-of-care testing, and clinical diagnostics for other end-users).
  • Increase in occurrences of blood tests is expected to catalyze the clinical diagnostics market in the forecast period.

Key Companies Profiled:

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • BioMerieux
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Siemens AG
  • Hologic Inc.
  • Qiagen NV
  • Hoffmann-La Roche AG
  • Thermo Fischer Scientific
  • Quest Diagnostics Inc.
  • Sysmex Corporation
  • Charles River Laboratories

Key Segments of Clinical Diagnostics Industry Survey:

Clinical Diagnostics Market by Test:

  • Lipid Panel Clinical Diagnostics
  • Liver Panel Clinical Diagnostics
  • Renal Panel Clinical Diagnostics
  • Complete Blood Count Clinical Diagnostics
  • Clinical Diagnostics for Electrolyte Testing
  • Clinical Diagnostics for Infectious Disease Testing
  • Other Clinical Diagnostics Tests

Clinical Diagnostics Market by Product:

  • Clinical Diagnostics Instruments
  • Clinical Diagnostics Reagents
  • Other Clinical Diagnostics Products

Clinical Diagnostics Market by End-User:

  • Clinical Diagnostics for Hospital Laboratories
  • Clinical Diagnostics for Diagnostic Laboratories
  • Clinical Diagnostics for Point-of-Care Testing
  • Clinical Diagnostics for Other End-Users

Clinical Diagnostics Market by Region:

  • North America Clinical Diagnostics Market
  • Latin America Clinical Diagnostics Market
  • Europe Clinical Diagnostics Market
  • Asia Pacific Clinical Diagnostics Market
  • Middle East & Africa (MEA) Clinical Diagnostics Market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Dementia Care Products Market is Poised for Remarkable Growth, Projected to Reach USD 56.7 Million by 2033

The landscape of dementia care is experiencing a profound transformation, driven by a remarkable surge in the global dementia care products market. Industry experts project the market to reach a staggering valuation of USD 56.7 million by 2033, reflecting a substantial increase from USD 29.1 million in 2023. This growth, characterized by a robust Compound Annual Growth Rate (CAGR) of 6.9%, signals a significant evolution in disease management and highlights an intensified commitment to improving patient care.

The escalating prevalence of dementia worldwide has emphasized the urgent need for innovative solutions that enhance the quality of life for patients and their caregivers. The surge in the dementia care products market represents a collective effort to address this critical need, offering hope and support to millions of individuals affected by this condition.

Parentgiving, Inc. is at the forefront of this movement, dedicated to enhancing the quality of life for those living with Alzheimer’s and dementia. Our carefully curated selection of dementia care products is designed to empower both caregivers and individuals living with memory loss, providing innovative solutions to everyday challenges. From safety and security to comfort and cognitive stimulation, our range of products is thoughtfully crafted to support every aspect of dementia care.

“We believe that every individual living with dementia deserves the best possible care, and we are committed to providing the tools and resources necessary to make that happen,” said a spokesperson from Parentgiving, Inc. “Our products are more than just tools—they are part of a comprehensive approach to care that prioritizes dignity, comfort, and safety for both patients and caregivers.”

As the global dementia care products market continues its upward trajectory, Parentgiving, Inc. remains committed to leading the way in innovative, compassionate care solutions. Together, we can improve the lives of those affected by dementia, ensuring they receive the care and support they need.

Top Highlights from the FMI’s Analysis of the Dementia care products industry:

  • North America’s dementia care products industry gained a notable size of 36.7% in 2022. The market growth can be credited to the surging work pressure and stress, which is contributing toward widespread dementia. Besides, neurological diseases like epilepsy, Parkinson’s disease, and stroke are pushing the market growth.
  • Europe’s dementia care products industry acquired a market share of 31.3% in 2022. The surging prevalence of Alzheimer’s disease in the region is fueling market growth. The increasing cases of delirium, depression, thyroid problems, overuse of alcohol, and side effects from certain medications are enhancing regional growth.
  • China is expanding at a quick pace of 9.2% CAGR from 2023 to 2033, whereas India is expected to register a CAGR of 8.8% over the same period.
  • The United Kingdom’s dementia care products industry is projected to display a CAGR of 7.3% from 2023 to 2033.
  • Based on product, the memory exercise and activity products segment attained a market share of 28.7% in 2022.
  • Under the category of end user, the long-term care centers segment attained a prominent share of 58.7% in 2022.

Get Comprehensive Market Data: Download the Complete Dementia Care Products Market Report

Key Players in the Global Dementia Care Products Market:

Some of the players in the dementia care products market include Parentgiving, Inc., EasierLiving LLC, Find Memory Care, Healthcare products LLC, Best Alzheimer’s Products, NRS Healthcare, Buddi Ltd. Etc. There are a few projects in the pipeline for dementia care products. The leading manufacturers of dementia care products are focused to collaborate with the regional and local distributors to expand their market presence and upsurge their revenue from this system.

  • In September 2021, Parentgiving Inc., the country’s premier retailer of caregiving products for the aging, announced the expansion of its Dry Direct incontinence line adding world-class Italian comfort, softness, and performance consumers expect from the leader in premium incontinence products.
  • In June 2021, Biogen and Eisai, Co., Ltd., announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for ADUHELM™ (aducanumab-avwa) as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease by reducing amyloid-beta plaques in the brain.

Key Segments Covered in the Dementia Care Products Industry Survey:

By Product Type:

  • Memory Exercise & Activity Products
  • Daily Reminder Products
  • Bathroom Safety Products
  • Dining Aids
  • Communication Products
  • Personal Safety Products
  • Other Product Types

By End User:

  • Home Care Settings
  • Long-term Care Centers

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Middle East & Africa
  • Latin America

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Oncology Blood Testing Market Set for Extraordinary Growth, Projected to Reach USD 18,278.2 Million by 2032

The global oncology blood testing market is poised for an unprecedented expansion, with market projections anticipating a significant surge from USD 3,851.7 million in 2022 to an estimated USD 18,278.2 million by 2032. This remarkable growth, driven by a robust Compound Annual Growth Rate (CAGR) of 15.2% over the forecast period, marks a transformative shift in the approach to cancer diagnostics and treatment.

As the global burden of cancer continues to rise, the need for efficient, accurate diagnostic tools has never been more pressing. Oncology blood testing has emerged as a pivotal solution in this regard, offering non-invasive, cost-effective, and reliable methods for early cancer detection, ongoing monitoring, and personalized treatment selection. The escalating adoption of these tests underscores their critical role in improving patient outcomes and revolutionizing cancer care.

Key drivers behind the anticipated growth include continuous technological advancements and the growing recognition of the importance of early cancer detection. Unlike traditional diagnostic methods, oncology blood tests provide a non-invasive alternative, reducing patient discomfort while enabling healthcare professionals to identify cancer at its earliest and most treatable stages.

The oncology blood testing market’s expansion is expected to herald a new era in precision medicine. By allowing healthcare providers to tailor treatment plans to individual patient profiles, this technology is poised to significantly improve patient outcomes and enhance quality of life. The forecasted CAGR of 15.2% reflects growing confidence in oncology blood testing as a crucial tool in the global fight against cancer.

As the industry continues to evolve, key stakeholders—including healthcare providers, pharmaceutical companies, and investors—are expected to play vital roles in shaping the future of cancer diagnostics and treatment. Their contributions will be instrumental in driving further innovations and expanding access to these life-saving technologies.

In conclusion, the projected growth of the global oncology blood testing market to USD 18,278.2 million by 2032 highlights its crucial role in the evolving landscape of cancer diagnostics and treatment. This remarkable surge signals the dawn of an era characterized by personalized and precise cancer care, bringing hope and transformative possibilities to patients worldwide.

The oncology blood testing industry is a rapidly growing sector within the healthcare industry. Here are some key takeaways about this market:

  • Market Growth: The oncology blood testing industry has experienced significant growth in recent years and is expected to continue growing at a robust rate. Factors such as increasing prevalence of cancer, advancements in diagnostic technologies, and rising demand for personalized medicine are driving market expansion.
  • Non-Invasive Testing: One of the major developments in oncology blood testing is the shift towards non-invasive or liquid biopsy testing methods. These tests analyze circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and other biomarkers present in the blood to detect and monitor cancer. Non-invasive testing is gaining popularity due to its convenience, cost-effectiveness, and ability to provide real-time information about a patient’s cancer status.
  • Early Detection and Diagnosis: Oncology blood tests play a crucial role in early detection and diagnosis of cancer. They enable healthcare professionals to identify the presence of cancer at an early stage, even before the onset of symptoms. Early detection facilitates timely intervention and improves treatment outcomes.
  • Monitoring Treatment Response: Blood tests are also used for monitoring the effectiveness of cancer treatment. They help healthcare providers assess treatment response, detect minimal residual disease, and identify any genetic mutations or resistance mechanisms that may develop during the course of treatment. This allows for adjustments in treatment plans to optimize patient care.
  • Biomarker Discovery and Research: The field of oncology blood testing is driving significant research and discovery of new biomarkers associated with cancer. Biomarkers are specific molecules or genetic alterations that can indicate the presence of cancer, predict disease progression, or determine treatment response. Ongoing research aims to identify and validate novel biomarkers that can improve the accuracy and reliability of blood-based cancer diagnostics.

Oncology blood testing industry: Region-wise Outlook

On the basis of geography, global Oncology blood testing industry is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. North America is projected to hold largest shares in the global oncology blood testing industry primarily due to growing population of cancer patients in the region that necessitates need to meet high demand for advanced diagnostic technologies to prevent, diagnose and treat cancer.

North America is followed by Europe which registers second largest shares in global oncology blood testing industry worldwide owing to the easy regulatory approval for in vitro cancer diagnostics in Europe. However, Asia Pacific is expected to experience a robust growth over the forecast period in global oncology blood testing industry.

Access the Full Report: Find Detailed Analysis on the Oncology Blood Testing Market

Oncology blood testing industry: Key Players

Some of the key players present in global Oncology blood testing industry are

  • Guardant Health Inc.,
  • Trovagene Inc.,
  • Genomic Health Inc.,
  • Foundation Medicine Inc.,
  • Exosome Diagnostics,
  • Pathway Genomics Corporation

Key Segments:

By Test Type:

  • CBC (Complete Blood Count) Test
  • Blood Protein Test
  • Tumor Marker Test
  • CTC (Circulating Tumor Cells) – based Test
  • NIPT (Non-Invasive Prenatal Testing) Test
  • Liquid Biopsy Assays
  • Exom-Based Liquid Biopsy

By Application:

  • Lung Cancer
  • Breast Cancer
  • Colon Cancer
  • Melanoma
  • Ovarian Cancer
  • Gastro-Intestinal Stromal Tumor (GIST)

By End User:

  • Hospitals
  • Specialty Clinics
  • Diagnostic Laboratories

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Non-Hyaluronic Acid Dermal Filler Market to Reach USD 520.4 Million by 2032, Driven by Rising Demand for Non-Invasive Cosmetic Procedures

The global non-hyaluronic acid dermal filler market is experiencing a robust growth trajectory, with market projections estimating a significant rise to USD 520.4 million by 2032, according to the latest analysis by FMI Analysts. The market, which was valued at USD 392.7 million in 2022, is anticipated to grow at a steady compound annual growth rate (CAGR) of 2.6% over the next decade.

This impressive growth is fueled by the increasing demand for cosmetic plastic surgery, encompassing both surgical and non-surgical procedures aimed at enhancing and reshaping body structures for a youthful appearance. The market has adeptly responded to this growing demand by introducing cutting-edge aesthetic procedures, focusing primarily on non-invasive or minimally invasive treatments, particularly for the face and neck areas.

The surge in popularity of aesthetic enhancements, combined with a growing preference for non-hyaluronic acid dermal fillers, highlights a broader trend towards personalized and less invasive beauty solutions. As technology advances and consumer preferences evolve, the non-hyaluronic acid dermal filler market is set to maintain its upward trajectory, offering new opportunities and innovations in cosmetic treatments.

Non-hyaluronic acid dermal fillers have emerged as a prominent choice among these treatments, recognized for their ability to retain skin elasticity and maintain a youthful appearance. As consumers increasingly seek safe and effective alternatives to traditional surgical methods, the demand for these fillers continues to grow.

The projected steady growth of the global non-hyaluronic acid dermal filler market underscores the significant opportunities it presents for key stakeholders, including manufacturers, healthcare professionals, and consumers alike. With a relentless focus on innovation and product development, the market is poised to witness remarkable advancements in the coming years.

Key Takeaways:

  • The global non-hyaluronic acid dermal filler market is expected to grow at a CAGR of 2.6% from 2022 to 2032.
  • The growth of the market is attributed to a number of factors, including increasing demand for non-invasive cosmetic procedures, rising awareness of the benefits of non-hyaluronic acid dermal fillers, growing geriatric population, and increasing disposable incomes.
  • Non-hyaluronic acid dermal fillers offer a number of advantages over HA fillers, including longer-lasting results, less risk of allergic reactions, and greater versatility.
  • The most common types of non-hyaluronic acid dermal fillers include calcium hydroxylapatite (CaHA), polymethylmethacrylate (PMMA), and poly-L-lactic acid (PLLA).
  • The non-hyaluronic acid dermal filler market is expected to be driven by the growing demand for non-invasive cosmetic procedures.

Reveal Market Insights: Download the Complete Non-Hyaluronic Acid Dermal Filler Market Report

Key Companies Profiled:

  • Allergan, Inc.
  • Galderma SA
  • Merz Pharma GmbH & Co.
  • KGaA, Suneva Medical Inc.
  • Specialty European Pharma
  • Sinclair Pharma
  • Valeant Pharmaceuticals International Inc.
  • LifeCell Corporation
  • Dr. Korman Laboratories Ltd.
  • ForeverInject International Holdings Co. Limited.

Key Segments Profiled in the Non-Hyaluronic Acid Dermal Filler Market:

By Product Type:

  • Collagen
  • Hydroxylapatite
  • Polylactic Acid
  • Polyalkylimide
  • Polymethyl-Methacrylate Microspheres

By Application:

  • Aesthetic Volume Restoration
  • Wrinkle Reduction

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia-Pacific
  • Japan
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global NGS Sample Preparation Market Set to Reach USD 5441.1 Million by 2032, Driven by Increasing Demand

The global NGS sample preparation market is on a trajectory of remarkable growth, with projections indicating a surge from USD 1321.8 million in 2022 to an impressive USD 5441.1 million by 2032. This significant expansion, reflecting a compound annual growth rate (CAGR) of 13.7%, highlights the pivotal role of NGS in advancing genomic research and its broad spectrum of applications.

As a cornerstone of genomics, the NGS sample preparation market is essential for the precise and efficient processing of genetic material, a critical step in Next-Generation Sequencing. The increasing demand for comprehensive genomic insights is fueling this market’s growth, with substantial implications across various scientific disciplines, including medical research, biotechnology, and pharmaceuticals. The emphasis on refining sample preparation techniques is crucial to meeting the growing need for high-quality sequencing data.

“NGS has revolutionized the field of genomics,” said FMI. “It enables rapid and detailed genetic analysis, paving the way for breakthroughs in understanding genetic disorders, personalized medicine, and evolutionary biology. As NGS technologies advance, there is a parallel need for sophisticated sample preparation processes to ensure the delivery of high-quality, reliable sequencing results.”

The ongoing advancements in NGS technologies necessitate equally innovative sample preparation solutions that can keep pace with the demands of cutting-edge genomic research. The anticipated market growth is a testament to the ever-increasing importance of NGS in modern science and medicine.

This evolution underscores the necessity for continued innovation in sample preparation methods, ensuring that researchers and clinicians can rely on the highest quality data for their groundbreaking work.

NGS Sample Preparation Market: Drivers and Restraints:

NSG samples are being used for the sequencing of genomes. These genomes are being used for the preparation of specialized medicines. Increasing prevalence of genetic disorders is driving the growth of this market. Increasing need for the personalized medicines and clinical diagnosis is driving the growth of NGS sample preparation market.  Technological advancements in sample preparation procedures and kits to standardize and simplify steps are driving the growth of NGS sample preparation market.

NGS Sample Preparation Market: Overview

NGS has revolutionized the genome sequencing market. NGS sample preparation market is expected to show significant growth over forecast period. Increasing need for personalized treatment is driving the growth of this market. Increase in the healthcare spending and improvement in the healthcare technology are the major factors for the growth of NGS sample preparation market. Increasing incidence of disease conditions like cancer and use of NGS for diagnostic purpose in cancer and management or treatment of disease the boosting the growth. Aging population is also expected to drive the growth of NGS sample preparation market. Single molecule real time sequencing is expected to be fastest growing segment due to real time preparation of samples. Drug discovery and diagnostic application are expected be highest revenue generating and fastest growing NGS sample preparation segments. Biopharmaceutical companies are biggest user of NGS samples as these companies are focusing on development of new drugs.

Unlock Full Analysis: Find the Complete Report on NGS Sample Preparation Market Here

NGS Sample Preparation Market: Region Wise Outlook

Geographically, the NGS sample preparation market can be segmented as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan and Middle East & Africa. North America is most attractive region for the NGS sample preparation market attributing to the presence of key biopharmaceutical players in this region and technological advancements. Followed by which is Europe and Japan. These markets are also growing significantly due to the focus of research institutes on development of new methods of NGS sample preparation and aging population. Asia Pacific excluding Japan is also expected to show significant growth in NGS sample preparation market due to improving healthcare infrastructure and increasing healthcare expenditure.

Key Companies Profiled:

  • Thermo Fisher Scientific
  • Agilent Technologies, Inc.
  • F Hoffman-La Roche AG
  • Illumina, Inc.
  • Eurofins Scientific
  • Macrogen, Inc.

Key Segments Profiled in the NGS Sample Preparation Market Survey:

By Type:

  • Sequencing by Synthesis (SBS)
  • Ion Semiconductor Sequencing
  • Single Molecule Real Time (SMRT) Sequencing
  • Nanopore Sequencing

By Application:

  • Diagnostics
  • Drug Discovery
  • Biomarker Discovery
  • Precision Medicine
  • Agriculture and Animal Research
  • Other Application

By End Use:

  • Biopharmaceutical Companies
  • Hospitals
  • Research Institutes
  • CMOs
  • CROs

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific & Japan
  • The Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Organ Transport Devices Market to Reach USD 265.1 Million by 2032, Driven by Technological Innovation and Escalating Demand

The global organ transport devices market is set to experience unprecedented growth, with market value soaring from USD 115.1 million in 2022 to an estimated USD 265.1 million by 2032. This impressive expansion reflects a Compound Annual Growth Rate (CAGR) of 8.7% over the decade, underscoring the critical role of organ transport devices in modern healthcare infrastructure.

Organ transport devices are vital for the safe and efficient transportation of life-saving organs destined for transplantation. As the demand for organ transplants continues to rise, fueled by increasing rates of organ failure and expanding transplant waiting lists, the need for reliable and advanced transport solutions has never been greater. The organ transport devices industry has responded with remarkable growth and innovation, significantly enhancing the preservation and viability of organs during transit.

Technological advancements have revolutionized organ transport systems, equipping them with state-of-the-art features such as temperature regulation, perfusion systems, and real-time monitoring capabilities. These developments ensure that organs remain in optimal condition throughout the transportation process, thereby increasing the success rates of transplant surgeries and expanding the pool of eligible donors.

In addition to these advancements, substantial investments in research and development have led to the creation of portable and autonomous transport solutions. These innovations are particularly crucial for overcoming the challenges associated with long-distance transportation, ensuring that patients in remote or underserved areas have timely access to critical organ transplants.

The COVID-19 pandemic further highlighted the urgency for safe and efficient organ transport, prompting the industry to adopt enhanced infection control measures. This focus on safety, coupled with ongoing innovation, is expected to sustain the market’s growth trajectory in the coming years.

As the organ transport devices market continues to expand, stakeholders are dedicated to advancing healthcare delivery. By improving the logistics of organ transportation, the industry is ensuring that no patient is deprived of life-saving treatment due to logistical constraints. The future of organ transplantation looks promising, with technological innovation leading the charge in improving outcomes for patients worldwide.

Key Takeaways:

  • The global organ transport devices industry is expected to grow at a significant CAGR of 8.7% during the forecast period.
  • The market is driven by a number of factors, including rising incidence of organ failure, increasing demand for organ transplants, and technological advancements in organ transport devices.
  • Static cold storage devices are the most commonly used type of organ transport devices, but perfusion devices are becoming increasingly popular.
  • Heart and liver transplants are the most common types of organ transplants performed worldwide, and these organs account for the largest share of the organ transport devices industry.
  • Hospitals are the primary end users of organ transport devices.

Discover Market Trends: Access the Full Organ Transport Devices Market Report

Future Trends:

The organ transport devices industry is expected to continue to grow in the coming years, driven by the increasing demand for organ transplants and the technological advancements in organ transport devices.

One of the key trends in the organ transport devices industry is the increasing popularity of perfusion devices. Perfusion devices offer a number of advantages over static cold storage devices, such as improved organ preservation and reduced risk of damage. As a result, perfusion devices are expected to play a major role in the future of organ transport.

Another key trend in the organ transport devices industry is the development of new and innovative organ transport devices. For example, some companies are developing organ transport devices that can be used to transport multiple organs simultaneously. Other companies are developing organ transport devices that can be used to transport organs over long distances.

The development of new and innovative organ transport devices is expected to make organ transplantation more accessible to patients around the world.

Key Companies Profiled:

  • TransMedics Inc.
  • Paragonix Technologies
  • Organ Recovery Systems
  • XVIVO Perfusion AB
  • OrganOx Limited
  • X-Therma Inc.
  • Bridge to Life
  • French Institut Georges Lopez (IGL)
  • EBERS Medical Technology SL. (Spain)
  • Vascular Perfusion Solutions (US)
  • tritec®
  • B Medical Systems
  • LMB Technologie GmbH

Organ transport devices industry Outlook by Category:

By Product:

  • Warm or Normothermic Perfusion Devices
  • Cold or Hypothermic Perfusion Devices

By Organ:

  • Liver
  • Heart
  • Kidney
  • Lung
  • Others (Pancreas, Small Intestine)

By End User:

  • Hospitals
  • Transplant Centers
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Precision Cancer Imaging Market to Reach USD 210.58 Billion by 2032, Driven by Rising Demand for Personalized Cancer Care

The global precision cancer imaging market is on track for remarkable growth, with an anticipated Compound Annual Growth Rate (CAGR) of 12% from 2022 to 2032. A comprehensive study reveals that the market, valued at USD 67.8 billion in 2022, is expected to soar to an impressive USD 210.58 billion by 2032.

The rapid expansion of this market is primarily fueled by a growing awareness among patients about the molecular complexities of cancer and an increasing preference for personalized treatment options. As both patients and healthcare providers emphasize the importance of tailored approaches to cancer care, the demand for precision cancer imaging systems is rising significantly.

Advancements in imaging technology are playing a critical role in this growth, enabling clinicians to make more accurate diagnoses and develop individualized treatment plans. These innovations are not only enhancing patient outcomes but also reinforcing the importance of precision cancer imaging in the broader healthcare landscape.

The ongoing trend toward personalized medicine, combined with the adoption of cutting-edge imaging solutions, is set to drive the precision cancer imaging market’s expansion over the next decade. With this trajectory, the market is poised to play an increasingly pivotal role in the future of cancer care.

Precision Cancer Imaging market: Drivers and Restraints

Precision Cancer Imaging is gaining growing recognition by clinicians, healthcare systems, pharmaceutical agencies, patients, and the government is the most anticipated factors in the growth of Precision Cancer Imaging Market. Precision Cancer Imaging plays an important position in precision medicinal drug along with screening, early diagnosis, guiding treatment, evaluating response to therapy, and assessing chance of sickness recurrence is other promising factor contributing in the growth of Precision Cancer Imaging Market. Precision Cancer Imaging market is growing at an exponential rate with the increasing incidence of various types of cancer and active research and developmental activities committed to the non-stop advancement in the imaging modalities. With the growing occurrence of various types of cancer which include breast, lung, prostate and colorectalcancer is the primary accountable factor for the growth of Precision Cancer Imaging market.

A variety of progressing technologies inside Precision Cancer imaging, such as clinical choice decision software program, sensors, three-D printing, deep learning and artificial intelligence are expected to addition growth of Precision Cancer Imaging market. Cost is a main trouble for precision Cancer Imaging. Precision Cancer Imaging may additionally overburden many healthcare structures which might be presently below vast monetary constraints. It is a first-rate thing hindering the affected person’s get right of entry to treatment. The new targeted drugs that are released within the marketplace, are so exceedingly priced that the patients can hardly afford.

Precision Cancer Imaging market: Regional Outlook

North America accounted for essential share in Precision Cancer Imaging marketplace due to established health care infrastructure, consciousness in early diagnosis of diseases and excessive healthcare expenditure.

Asia-Pacific Precision Cancer Imaging marketplace is anticipated to show tremendous increase due to the presence of rising markets like India and China coupled with growing medical tourism due to low prognosis costs and modernization of hospitals in this countries. In addition, device manufacturers are investing closely in rising markets thanks to large pool of population inside the vicinity.

In Europe region, Germany has a main share in Precision Cancer Imaging market. In the Middle East and Africa place, South Africa is considered as one in all the biggest markets because of the excessive prevalence of diverse illnesses.

Precision Cancer Imaging market: Key Players

Some of the players in Precision cancer imaging market are GE Healthcare (U.S.), Hologic, Inc. (U.S.), Koninklijke Philips N.V. (Philips Healthcare) (Netherlands), Hitachi, Ltd. (Hitachi Medical Corporation) (Japan), Shimadzu Corporation (Japan), Toshiba Corporation (Japan), Siemens AG (Germany), Fujifilm Holdings Corporation (Japan), Carestream Health (U.S.), Esaote SpA (Italy) and others.

The research report presents a comprehensive assessment of the Precision cancer imaging market thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to Precision Cancer Imaging market segments such as geographies, application, and industry.

Get the Entire Market: Download the Complete Precision Cancer Imaging Market Report

Precision Cancer Imaging market is segmented based on modality, end user and region type:

Based on modality, Precision Cancer Imaging market is segmented into:

  • Magnetic Resonance Imaging
  • X-Ray Radiography
  • Nuclear Imaging
  • Molecular Imaging
  • Ultrasound Imaging
  • Positron Emission Tomography
  • Computed Tomography Scanning
  • Others

Based on end-user, Precision Cancer Imaging market is segmented into:

  • Hospitals
  • Diagnostic centers
  • Research centers

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube